Morrisville-based Novan presses ahead in fight against cervical cancer
A U.S. Department of Defense grant will support Morrisville-based Novan’s efforts to develop a new defense against cervical cancer. Here are the details.
Read MorePosted by WRAL TechWire | Sep 26, 2019
A U.S. Department of Defense grant will support Morrisville-based Novan’s efforts to develop a new defense against cervical cancer. Here are the details.
Read MorePosted by WRAL TechWire | Sep 20, 2019
Novan has received a $1.1 million grant from the U.S. Department of Defense to support its cancer research program.
Read MorePosted by WRAL TechWire | Sep 6, 2019
Pharmaceutical development firm Novan is bolstering both its finances and executive team with moves announced this week.
Read MorePosted by WRAL TechWire | May 6, 2019
Headlines from tech and life science companies in the Triangle and NC includes new funding for Novan, credit line update for Aerie, a new Piedmont Natural Gas plant, and more.
Read MorePosted by WRAL TechWire | May 1, 2019
Here’s a roundup of news from Triangle-area tech and life science firms, from funding to financials to mobile health: Novan Secures Up to $35 Million in Non-Dilutive Funding Validic and Welldoc Partner to Enhance Engagement for Individuals Living with Chronic Conditions Precision BioSciences Reports First Quarter 2019 Financial Results...
Read MorePosted by WRAL TechWire | Jan 31, 2019
Novan, Inc., a late-stage pharmaceutical company, continues to change its leadership as it plans to meet with the U.S. Food and Drug Administration in March, the company announced Wednesday.
Read MorePosted by WRAL News | Jan 21, 2019
Earlier this week, the company received a notice from Nasdaq that for the last 30 consecutive business days, the market value of the company’s stock has been below the minimum $50 million requirement.
Read MorePosted by WRAL TechWire | Jan 11, 2019
Novan Inc., a clinical-stage biotechnology company, continues to change its leadership as the company shifts its strategic focus, according to a Securities and Exchange Commission filing on Thursday.
Read MorePosted by WRAL TechWire | Jan 2, 2019
Paula Brown Stafford, a former senior executive at Quintiles, is now president and chief operating officer at drug development firm Novan.
Read More